1. Home
  2. HRL vs UTHR Comparison

HRL vs UTHR Comparison

Compare HRL & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRL
  • UTHR
  • Stock Information
  • Founded
  • HRL 1891
  • UTHR 1996
  • Country
  • HRL United States
  • UTHR United States
  • Employees
  • HRL N/A
  • UTHR N/A
  • Industry
  • HRL Meat/Poultry/Fish
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HRL Consumer Staples
  • UTHR Health Care
  • Exchange
  • HRL Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • HRL 15.7B
  • UTHR 14.4B
  • IPO Year
  • HRL N/A
  • UTHR 1999
  • Fundamental
  • Price
  • HRL $30.58
  • UTHR $284.73
  • Analyst Decision
  • HRL Buy
  • UTHR Buy
  • Analyst Count
  • HRL 4
  • UTHR 12
  • Target Price
  • HRL $33.50
  • UTHR $388.25
  • AVG Volume (30 Days)
  • HRL 3.6M
  • UTHR 499.4K
  • Earning Date
  • HRL 05-29-2025
  • UTHR 04-30-2025
  • Dividend Yield
  • HRL 3.79%
  • UTHR N/A
  • EPS Growth
  • HRL N/A
  • UTHR 24.38
  • EPS
  • HRL 1.38
  • UTHR 24.64
  • Revenue
  • HRL $11,912,699,000.00
  • UTHR $2,877,400,000.00
  • Revenue This Year
  • HRL $2.68
  • UTHR $11.52
  • Revenue Next Year
  • HRL $2.25
  • UTHR $6.08
  • P/E Ratio
  • HRL $22.17
  • UTHR $11.56
  • Revenue Growth
  • HRL N/A
  • UTHR 23.63
  • 52 Week Low
  • HRL $27.59
  • UTHR $233.28
  • 52 Week High
  • HRL $36.86
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • HRL 54.84
  • UTHR 37.49
  • Support Level
  • HRL $30.07
  • UTHR $266.98
  • Resistance Level
  • HRL $30.97
  • UTHR $288.54
  • Average True Range (ATR)
  • HRL 0.90
  • UTHR 14.43
  • MACD
  • HRL -0.00
  • UTHR -0.15
  • Stochastic Oscillator
  • HRL 54.71
  • UTHR 38.23

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and become a branded food company. The firm sells its wares through multiple channels, including US retail (62% of fiscal 2024 sales), US food service (32%), and international (6%). By product, 72% of fiscal 2024 sales were from perishable food and 28% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: